Work

A pilot trial of G3139, a bcl-2 antisense oligonucleotide,and paclitaxel in patients with chemorefractory small-cell lung cancer

Year: 2002

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdf124

Authors: C.M. Rudin, G.A. Otterson, A.M. Mauer, M.A. Villalona-Calero, R. Tomek, B. Prange, C.M. George, L. Szeto, E.E. Vokes

Institutions: University of Chicago Medical Center, The Ohio State University

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: V Foundation for Cancer Research, National Institutes of Health, National Cancer Institute

Awards: COOPERATIVE STUDY, G2100797677, GENETIC AND GENOMIC RESPONSES TO DNA DAMAGE, G231806823, Phase I Trials of Anti-Cancer Agents, G6358387475, Cancer Center Support Grant, G965719224

OpenAlex ID: W2151190428

FWCI: 9.187

Cites: 50

Cited by: 155

Related to: 10